Shandong Retained Earnings from 2010 to 2024

000756 Stock   16.07  0.06  0.37%   
Shandong Xinhua's Retained Earnings are increasing over the years with slightly volatile fluctuation. Retained Earnings are expected to dwindle to about 1.7 B. Retained Earnings is the cumulative amount of net income that Shandong Xinhua Pharmaceutical retains for reinvestment in its operations, rather than distributing it to shareholders as dividends. View All Fundamentals
 
Retained Earnings  
First Reported
2018-06-30
Previous Quarter
2.4 B
Current Value
2.5 B
Quarterly Volatility
489.5 M
 
Covid
Check Shandong Xinhua financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Shandong Xinhua's main balance sheet or income statement drivers, such as Interest Expense of 38.3 M, Selling General Administrative of 800.1 M or Total Revenue of 6.2 B, as well as many indicators such as . Shandong financial statements analysis is a perfect complement when working with Shandong Xinhua Valuation or Volatility modules.
  
This module can also supplement various Shandong Xinhua Technical models . Check out the analysis of Shandong Xinhua Correlation against competitors.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Other Information on Investing in Shandong Stock

Shandong Xinhua financial ratios help investors to determine whether Shandong Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Shandong with respect to the benefits of owning Shandong Xinhua security.